These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9407218)

  • 1. Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
    Tiballi RN; Spiegel JE; Zarins LT; Kauffman CA
    Diagn Microbiol Infect Dis; 1995 Dec; 23(4):135-40. PubMed ID: 9407218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
    Pfaller MA; Messer S; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):233-5. PubMed ID: 9021172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
    Pfaller MA; Barry AL
    Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
    Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of antifungal resistance.
    Espinel-Ingroff A
    Infect Dis Clin North Am; 1997 Dec; 11(4):929-44. PubMed ID: 9421708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
    Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
    J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
    Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
    Pfaller MA; Buschelman B; Bale MJ; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG
    Diagn Microbiol Infect Dis; 1994 May; 19(1):9-13. PubMed ID: 7956018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
    Zhang J; Hollis RJ; Pfaller MA
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):63-7. PubMed ID: 9147006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.
    Boon-Long J; Mekha N; Poonwan N; Kusum M; Mikami Y; Yazawa K; Konyama K
    Mycoses; 1996; 39(11-12):453-6. PubMed ID: 9145003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D; Watelle M; Van der Flaes M; Nolard N
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.